1st Quarter - Report — BOEHRINGER INGELHEIM USA CORPORATION, F… for BOEHRINGER INGELHEIM USA CORPORATION (2017)

Firm

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

Client

BOEHRINGER INGELHEIM USA CORPORATION

Income

—

Expenses

$850,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Accounting ACC

Transparency - Fair Drug Pricing Act - Baldwin/McCain.

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Veterinary Biologics, S. 1200 (Fairness to Pet Owners Act).

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1200 (115th)

Health Issues HCR

Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 469 (115th), S.Con.Res. 3 (115th)

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; 21st Century Cures. CMS Part B Centers for Medicare and Medicaid Innovation Demonstration (CMMI); CMS Rule Blended J Code for Biosimilars.

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Prescription Drug User Fee Act VI reauthorization; 21st Century Cures Proposal.

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Non-Interference; and Drug Pricing. HR. 849 Protecting Seniors' Access to Medicare Act of 2017 (IPAB) Medicare S. Cong. Reg. 3 - 2017 Budget President's 2018 Budget Blue Print

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 849 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION